HPV vaccine for people living with HIV
Part of Infections clinical trials.
This trial tests an HPV vaccine in people living with HIV to see if it is safe and helps their immune system fight HPV. HPV can cause certain cancers, and this study hopes to protect people with HIV who are more at risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old and have HIV-1. (HIV-1 is the most common type of HIV.)
- You must have been on HIV medicines (called antiretroviral therapy, or ART) for at least 1 year.
- Your HIV viral load (the amount of virus in your blood) must be 1000 copies/mL or less.
- You must not have any current opportunistic infections (infections that happen more often because your immune system is weak).
- You must not have tested positive for HPV (the virus the vaccine is meant to prevent).
- You must not be pregnant, breastfeeding, or have had an HPV vaccine before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether getting the HPV vaccine along with regular cervical cancer screening (using an HPV test) can help prevent cervical cancer in women living with HIV. It is designed to be done as part of your usual HIV clinic visits, making it easier for you to take part.
This trial studies how well the Gardasil-9 HPV vaccine triggers the body’s immune response in people living with HIV. It may help doctors understand the best way to protect against HPV-related cancers and infections in this population.
This study looks at how well the HPV vaccine works in women living with HIV and whether it helps make cervical cancer screening more accurate. If you are a woman with HIV between 21 and 40 years old and already part of certain other HIV studies, you may be able to join.
This study tests how well the Gardasil 9 HPV vaccine works in people assigned male at birth, including those with HIV and those taking hormone therapy. Results could help protect against HPV-related cancers.
This trial tests a new way to prevent cervical cancer in women with both HIV and HPV. It focuses on women in India who are already on stable HIV treatment and have a normal cervical exam.
This trial tests whether giving a lower dose of the HPV vaccine can still be effective and safe for women living with HIV. It may be helpful if you need HPV protection and the study’s dose schedule could reduce vaccine burden.
Hear when a new HIV Infected Individuals trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.